RARS1 and metabolic dysfunction-associated steatotic liver disease: Ma et al. [32] suggested that the effect of Aldh1a1-induced RA content on NAFLD depends on whether it activates retinoic acid receptors (RARs) or retinoic acid X receptors (RXRs), and that RARs and RXRs have opposite effects on lipid regulation.